Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysis

AIDS

Volumn 16, Issue 17, 2002, Pages 2347-2349

  Holtgrave, David R ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; EPIDEMIC; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HEALTH CARE COSTS; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INCIDENCE; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; UNITED STATES;

EID: 0037159919     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200211220-00020     Document Type: Article

References (16)

1. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991, 253:37-42.
2. Holtgrave DR, Pinkerton SD. Implications of economic evaluation for national HIV prevention policy makers. In: Quantitative Evaluation of HIV Prevention Programs. Kaplan EH, Brookmeyer R (editors). New Haven, CT: Yale University Press; 2002. pp. 32-54.
3. Haddix AC, Teutsch SM, Shaffer PA, Duñet DO (editors). Prevention Effectiveness. New York: Oxford University Press; 1996.
4. Holtgrave DR (editor) Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Publishing; 1998.
5. World Bank. Confront AIDS: Public Priorities in a Global Epidemic. New York: Oxford University Press; 1999. p. 15.
6. Mann J, Tarantola D (editors). AIDS in the World II. New York: Oxford University Press; 1996. p. 19.
7. Anderson JE, Wilson RW, Barker P, Doll L, Jones TS, Holtgrave DR. Prevalence of sexual and drug-related HIV risk behaviors in US adult population: Results of the 1996 National Household Survey on Drug Abuse. J Acquir Immune Defic Syndr 1999, 21:148-156.
8. US Census Bureau. Historical National Population Estimates: July 1 1900 to July 1 1999. Internet release date: 11 April 2000 (revised 28 June 2000). World wide web address: www.census.gov/population/estimates/nation/popclockest.txt.
9. Karon JM, Fleming PL, Steketee RW, DeCock KM. HIV in the United States at the turn of the century: An epidemic in transition. Am J Pub Health 2001, 91:1060-1068.
10. US Census Bureau. Table no. 39: Cities with 100,000 or more inhabitants in 1998 - Population 1980 to 1998, and land area 1990. Statistical Abstract of the United States 2000.
11. Holtgrave DR. Reducing new HIV infections by one-half: What will it take? In: Putting the goal in historical context, and assessing the cost of unmet needs. Presented at the 2001 National HIV Prevention Conference. Atlanta, Georgia, 12-15 August 2001.
12. The Henry J. Kaiser Family Foundation. Federal HIV/AIDS Spending: A Budget Chartbook, Fiscal Year 2000. Menlo Park, CA: The Henry J. Kaiser Family Foundation; October 2000.
13. National Alliance of State and Territorial AIDS Directors. Fiscal Year; 2000.
14. Funders concerned about AIDS. Philanthropy and AIDS: Assessing the Past, Shaping the Future. Washington, DC: Funders Concerned About AIDS, 2000 (www.fcaaids.org).
15. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:54-62.
16. Guinan ME, Farnham PG, Holtgrave DR. Estimating the value of preventing an HIV infection. Am J Prevent Med 1994, 10:1-4.